Is sunitinib a Narrow Therapeutic Index Drug? – A systematic review and in vitro toxicology-analysis of Sunitinib vs. Imatinib in cells from different tissues

2016 ◽  
Vol 77 ◽  
pp. 25-34 ◽  
Author(s):  
Bodo Haas ◽  
Konstantin Weber-Lassalle ◽  
Roland Frötschl ◽  
Niels Eckstein
2010 ◽  
Vol 11 (3) ◽  
pp. 1359-1367 ◽  
Author(s):  
Rakhi B. Shah ◽  
Jarrod S. Collier ◽  
Vilayat A. Sayeed ◽  
Arthur Bryant ◽  
Muhammad J. Habib ◽  
...  

Pharmaceutics ◽  
2020 ◽  
Vol 12 (12) ◽  
pp. 1201
Author(s):  
Florian Klomp ◽  
Christoph Wenzel ◽  
Marek Drozdzik ◽  
Stefan Oswald

Cytochrome P450 (CYP) 1A enzymes are considerably expressed in the human intestine and liver and involved in the biotransformation of about 10% of marketed drugs. Despite this doubtless clinical relevance, CYP1A1 and CYP1A2 are still somewhat underestimated in terms of unwanted side effects and drug–drug interactions of their respective substrates. In contrast to this, many frequently prescribed drugs that are subjected to extensive CYP1A-mediated metabolism show a narrow therapeutic index and serious adverse drug reactions. Consequently, those drugs are vulnerable to any kind of inhibition or induction in the expression and function of CYP1A. However, available in vitro data are not necessarily predictive for the occurrence of clinically relevant drug–drug interactions. Thus, this review aims to provide an up-to-date summary on the expression, regulation, function, and drug–drug interactions of CYP1A enzymes in humans.


2021 ◽  
Vol 2021 ◽  
pp. 1-8
Author(s):  
Marzieh Nemati ◽  
Gholamhossein Ranjbar Omrani ◽  
Bahareh Ebrahimi ◽  
Nima Montazeri-Najafabady

Probiotics are living microorganisms increasingly used to treat or modulate different diseases or disorders because of their benefits and also low adverse reaction, and their positive and protective effects on various cells and tissues have been reported. The mechanisms by which probiotics exert their beneficial effects in different cells and tissues were investigated, and autophagy is one of the main mechanisms to induce their positive effects. Autophagy is a conserved process that occurs in all eukaryotic cells and plays an essential role in homeostasis and cell survival by degrading damaged and dysfunctional intracellular organelles. On the other hand, the role of autophagy is diverse in different tissues and situations, and cell death derived from autophagy has been observed in some cells. This search was done in PubMed, WOS, and Scopus using the keywords probiotic, microbiota, and autophagy. The search strategy was focused on the in vitro and animal model studies, and the included filters were English language publications and full-text articles (by June 2020). Studies that investigated other underlying mechanisms except autophagy were excluded. Among more than 105 papers, 24 studies were considered eligible for more evaluation. The obtained results indicated that most studies were performed on intestinal cell lines or tissue compared with other types of cell lines and tissue. This review article discusses our current understanding of the probiotic effects through autophagy in different cell lines and tissues that would be a useful guide to daily and clinical usage of these living microorganisms, but despite promising results of this systematic review, further studies need to assess this issue. This systematic review has demonstrated that autophagy is an effective mechanism in inducing beneficial effects of probiotics in different tissues.


2013 ◽  
Vol 61 (9) ◽  
pp. 1586-1591 ◽  
Author(s):  
Joshua J. Gagne ◽  
Jennifer M. Polinski ◽  
Aaron S. Kesselheim ◽  
Niteesh K. Choudhry ◽  
David Hutchins ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document